Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract.

Wang YW, Li WM, Wu WJ, Chai CY, Chang TY, Sun Y, Cheng CJ, Shiue YL, Su SJ, Cheng HL, Liu HS, Chow NH.

Am J Pathol. 2013 Sep;183(3):709-19. doi: 10.1016/j.ajpath.2013.05.015. Epub 2013 Jul 6.

PMID:
23838430
2.

Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.

Ohtsuka Y, Kawakami S, Fujii Y, Koga F, Saito K, Ando N, Takizawa T, Kageyama Y, Kihara K.

BJU Int. 2006 Jun;97(6):1322-6.

3.

Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.

Kosaka T, Kikuchi E, Mikami S, Miyajima A, Shirotake S, Ishida M, Okada Y, Oya M.

Clin Cancer Res. 2010 Dec 1;16(23):5814-23. doi: 10.1158/1078-0432.CCR-10-0230. Epub 2010 Oct 14.

4.

Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.

Kitamura H, Torigoe T, Hirohashi Y, Asanuma H, Inoue R, Nishida S, Tanaka T, Fukuta F, Masumori N, Sato N, Tsukamoto T.

Mod Pathol. 2013 Jan;26(1):117-24. doi: 10.1038/modpathol.2012.139. Epub 2012 Aug 17.

5.

Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma.

Yeh BW, Wu WJ, Li WM, Li CC, Huang CN, Kang WY, Liu ZM, Huang HS.

Am J Pathol. 2012 Sep;181(3):1044-55. doi: 10.1016/j.ajpath.2012.05.024. Epub 2012 Jul 5.

PMID:
22771156
6.

The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma.

Li CF, Wu WJ, Wu WR, Liao YJ, Chen LR, Huang CN, Li CC, Li WM, Huang HY, Chen YL, Liang SS, Chow NH, Shiue YL.

Oncotarget. 2015 Apr 20;6(11):9220-39.

7.

Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway.

Wang YW, Li WM, Wu WJ, Chai CY, Liu HS, Lai MD, Chow NH.

J Urol. 2014 Jul;192(1):242-51. doi: 10.1016/j.juro.2013.12.001. Epub 2013 Dec 10.

PMID:
24333112
8.
9.

Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.

Zigeuner R, Tsybrovskyy O, Ratschek M, Rehak P, Lipsky K, Langner C.

Urology. 2004 Jun;63(6):1079-83.

PMID:
15183954
10.

Molecular aspects of upper tract urothelial carcinoma.

Patel N, Arya M, Muneer A, Powles T, Sullivan M, Hines J, Kelly J.

Urol Oncol. 2014 Jan;32(1):28.e11-20. doi: 10.1016/j.urolonc.2012.10.002. Epub 2013 Feb 19. Review.

PMID:
23428541
11.

Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.

Munari E, Fujita K, Faraj S, Chaux A, Gonzalez-Roibon N, Hicks J, Meeker A, Nonomura N, Netto GJ.

Hum Pathol. 2013 Dec;44(12):2668-76. doi: 10.1016/j.humpath.2013.07.008. Epub 2013 Sep 27.

PMID:
24074531
12.

Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2.

Chen CC, Hsieh TF, Chang CH, Ma WL, Hung XF, Tsai YR, Lin MH, Zhang C, Chang C, Shyr CR.

Oncol Rep. 2013 Aug;30(2):979-85. doi: 10.3892/or.2013.2506. Epub 2013 May 28.

PMID:
23715826
13.

Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.

Kamai T, Shirataki H, Nakanishi K, Furuya N, Kambara T, Abe H, Oyama T, Yoshida K.

BMC Cancer. 2010 Apr 28;10:164. doi: 10.1186/1471-2407-10-164.

14.

Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.

Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, Asano T.

Urol Int. 2012;88(2):225-31. doi: 10.1159/000335274. Epub 2012 Jan 11.

PMID:
22236640
15.

[Molecular changes in development and progression of urothelial carcinoma].

Hartmann A.

Verh Dtsch Ges Pathol. 2003;87:172-84. Review. German.

PMID:
16888910
16.

Anabolic androgens affect the competitive interactions in cell migration and adhesion between normal mouse urothelial cells and urothelial carcinoma cells.

Huang CP, Hsieh TF, Chen CC, Hung XF, Yu AL, Chang C, Shyr CR.

Biochem Biophys Res Commun. 2014 Sep 26;452(3):322-7. doi: 10.1016/j.bbrc.2014.08.039. Epub 2014 Aug 23.

PMID:
25159849
17.

Expression of p53 in upper urinary tract urothelial carcinoma.

Mitchell S, Mayer E, Patel A.

Nat Rev Urol. 2011 Aug 2;8(9):516-22. doi: 10.1038/nrurol.2011.92. Review.

PMID:
21811225
18.

Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract.

Compérat E, Roupret M, Chartier-Kastler E, Bitker MO, Richard F, Camparo P, Capron F, Cussenot O.

J Urol. 2008 Mar;179(3):868-72; discussion 872. doi: 10.1016/j.juro.2007.10.079. Epub 2008 Jan 25.

PMID:
18221954
19.

Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.

Sung MT, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Cheng L.

Clin Cancer Res. 2008 Apr 1;14(7):1947-55. doi: 10.1158/1078-0432.CCR-07-4147.

20.

The potential use of primary human upper urinary tract urothelial cell carcinoma (UUT-UCC) cultured cells for prognostic indicators and chemosensitivity test.

Hsieh TF, Chen CC, Chang CH, Yu AL, Ma WL, Shyr CR.

Exp Toxicol Pathol. 2013 Jul;65(5):703-8. doi: 10.1016/j.etp.2012.09.003. Epub 2012 Oct 12.

PMID:
23069010
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk